Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

17.77
Delayed Data
As of 11:45am ET
 -0.22 / -1.22%
Today’s Change
15.53
Today|||52-Week Range
33.30
-13.06%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close17.99
Today’s open18.01
Day’s range17.29 - 18.22
Volume68,457
Average volume (3 months)268,131
Market cap$629.2M
Dividend yield--
Data as of 11:45am ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-112.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.35-2.62%
ACIUAC Immune Ltd+0.15+1.35%
VNDAVanda Pharmaceutical...-0.15-1.04%
KERXKeryx Biopharmaceuti...-0.16-2.68%
Data as of 12:04pm ET, 03/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs